Skip to main content
. 2020 Nov 9;10:19293. doi: 10.1038/s41598-020-76380-z

Table 2.

Results of meta-regression analyses assessing the association between HIV prevalence and HSV-2 prevalence among female sex workers globally.

Factors Studies Samples Univariable analyses Multivariable analysis-model 1 Multivariable analysis-model 2
Total n Total n OR (95% CI) p value F p valuea Adj. R2 (%) AOR (95% CI) p value F p valueb AORc (95% CI) p value F p valueb
HSV-2 prevalence
 < 25% 8 2410 1.0  < 0.01 10.8 1.0  < 0.01
 25–49% 23 8334 1.4 (0.4–5.0) 0.60 2.8 (1.2–6.3) 0.01
 50– 74% 92 35,830 4.0 (1.3–12.6) 0.02 5.2 (2.4–11.3)  < 0.01
 75–100% 71 21,072 7.2 (2.3–22.7)  < 0.01 13.4 (6.1–29.9)  < 0.01
HSV-2 prevalencec
191 66,239 1.03 (1.02–1.04)  < 0.01  < 0.01 10.8 1.04 (1.03–1.05)  < 0.01  < 0.01
WHO region
 AMRO 41 12,037 1.0  < 0.01 48.5 1.0  < 0.01 1.0  < 0.01
 AFRO 41 12,998 31.7 (19.0–53.0)  < 0.01 37.1 (23.2–59.4)  < 0.01 36.2 (23.6–55.7)  < 0.01
 EURO 3 718 1.3 (0.3–5.2) 0.70 3.5 (1.0–12.1) 0.05 5.5 (1.7–17.5)  < 0.01
 SEARO 71 24,047 8.5 (5.4–13.4)  < 0.01 11.2 (7.0–17.8)  < 0.01 12.5 (8.1–19.1)  < 0.01
 WPRO 38 17,846 3.8 (2.3–6.4)  < 0.01 5.8 (3.4–9.9)  < 0.01 6.2 (3.8–10.0)  < 0.01
Publication year
 < 2000 15 5049 1.0 0.83 0.0
 2000–2004 7 2368 1.2 (0.3–5.5) 0.80
 2005–2009 56 13,855 1.7 (0.6–4.3) 0.30
 2010–2014 99 40,760 1.4 (0.6–3.6) 0.44
 2015– 2019 17 5614 1.2 (0.4–3.7) 0.81
Data collection yeard
 < 1995 18 6478 1.0 0.11 1.8 1.0 0.15 1.0 0.17
 1995–1999 14 2462 1.0 (0.3–3.1) 0.97 0.7 (0.3–1.5) 0.31 0.7 (0.3–1.3) 0.26
 2000–2004 61 15,736 1.0 (0.4–2.5) 0.93 1.0 (0.6–1.7) 0.98 1.0 (0.6–1.6) 0.85
 2005–2009 88 37,770 2.0 (0.9–4.6) 0.10 1.4 (0.8–2.5) 0.30 1.3 (0.8–2.3) 0.34
 2010–2014 13 5200 1.4 (0.4–4.6) 0.56 0.6 (0.3–1.3) 0.19 0.6 (0.3–1.3) 0.22
Sample size
 < 200 52 5507 1.0 0.76 0.0
 ≥ 200 142 62,139 0.92 (0.54–1.56) 0.76
Proportion of FSWs reporting consistent condom use
 75–100% 77 31,462 1.0 0.09 2.1 1.0 0.09 1.0 0.08
 50–74% 19 8129 0.4 (0.2–1.0) 0.04 1.1 (0.6–1.9) 0.79 1.2 (0.7–2.0) 0.55
 25–49% 31 6367 1.4 (0.7–2.7) 0.38 1.8 (1.0–3.2) 0.05 1.9 (1.1–3.2) 0.02
 < 25% 9 3715 1.1 (0.3–3.3) 0.91 0.7 (0.3–1.5) 0.31 0.8 (0.4–1.6) 0.51
 Unclear 58 17,973 0.7 (0.4–1.2) 0.19 1.3 (0.8–2.1) 0.30 1.2 (0.8–1.8) 0.47

Adj, Adjusted; AFRO, African Region; AMRO, Region of the Americas; AOR, adjusted odds ratio; CI, confidence interval; EURO, European Region; FSWs, female sex workers; HSV-2, herpes simplex virus type 2; OR, odds ratio; SEARO, South-East Asia Region; WHO, World Health Organization; WPRO, Western Pacific Region.

Adjusted R2 is 65.3% in the multivariable model 1, and 70.6% in the multivariable model 2.

aFactors with p value ≤ 0.2 were eligible for inclusion in the multivariable analysis.

bFactors with p value ≤ 0.05 and those with 0.05 < p value ≤ 0.1 in the multivariable model were considered as showing, respectively, “strong” and “some” evidence for an association with HIV prevalence.

cAnalysis of the association with HSV-2 prevalence as a linear term excluded three measures with HSV-2 prevalence ≤ 20% in light of the observed threshold effect.

dMissing values for year of data collection were imputed using data for year of publication adjusted by the median difference between year of publication and median year of data collection for studies with complete information.